Navigation Links
Doctors fail to communicate impact of heart devices with patients, SLU study finds
Date:2/18/2013

ST. LOUIS New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat irregular heart rhythms, leaving them misinformed about how the device may affect quality of life.

The article, titled 'Patient Perceptions, Physician Communication and the Implantable Cardioverter-Defibrillator,' was published online in JAMA Internal Medicine (formerly Archives of Internal Medicine) on February 18.

For the study, 41 patients with ICDs and 11 cardiologists were recruited by a national marketing research company in three metropolitan areas. The patients participated in focus groups in which they described the nature of discussions they had with their doctors before the device was implanted. Multiple patients reported experiences such as depression, anxiety and changes in body image, which doctors had not mentioned.

"Getting an ICD is clearly a life-changing event for the patient," said Paul Hauptman, M.D., principal investigator of the study and professor of internal medicine at the Saint Louis University School of Medicine. "Physicians not only have to point out the benefits of this device, but also let the patients know about its risks beyond those of the implantation procedure itself."

In addition to the focus groups, Hauptman and his collaborators observed (from behind a glass mirror wall) the content and style of communication of cardiologists who met with standardized patients, individuals who are trained to act as real patients to simulate a real patient encounter.

"We were interested in how physicians communicate with patients and explain the impact of an expensive, invasive technology on quality of life," said Eric Armbrecht, Ph.D., co-principal investigator and director of consulting practice at Saint Louis University Center for Outcomes Research (SLUCOR). "This study revealed physicians talked more about the technology of the device instead of communicating the expectations patients should have from it."

An ICD is a device placed in the chest or abdomen of a patient that is used by physicians to treat abnormal electrical function of the heart called arrhythmia. The device provides electrical pulses or shocks to help control life-threatening cardiac arrests and is often regarded as a permanent safeguard against arrhythmias.

Hauptman said that asymptomatic patients often receive ICDs as part of a primary prevention strategy, despite the potential of several post-implantation complications that include anxiety and psychosocial changes. Primary prevention strategies are for patients who have not had a sudden death event or symptoms of life-threatening arrhythmias. In secondary prevention, patients have already experienced life threatening cardiac arrhythmias and benefit more from an ICD.

The device, like many technologies, is not free of defects and manufacturers have issued advisories about problems, some of which require corrective procedures to replace parts such as the lead and the generator.

"Seven to eight patients out of a 100 will accrue a survival benefit when the ICD is implanted for primary rather than secondary prevention. The majority will not gain a survival benefit over standard of care," Hauptman said. "Unfortunately, the screening methodology used to identify patients who are at risk of sudden death is not very good."

In the study, 80 percent of patients did not report discussing any potential long-term complications from the device with their physicians before the procedure. They also said that they were not warned about the changes they could expect in the quality of their lifestyles after implanting the device.

Multiple patient participants also experienced difficulty in performing routine physical labor and stated that they now dislike flying because of extra security screening at airports.

The study also found that most patients viewed the implantation as a cure, but soon realized that wasn't the case.

"Patients reported that their physicians described the device as a safety net, calling it absolutely necessary. We found that many patients end up having unrealistic expectations of what the technology is going to do for them," Armbrecht said.

"For moral, ethical and economic reasons, patients need to be equipped to make informed decisions about their own health. As health care continues using more expensive, complicated and invasive technologies like ICDs, it is imperative that the health care system assures patients have all of the information they need to make a decision."

Hauptman and colleagues have previously investigated the predictors of short term mortality with ICD implants and described national trends in use of these devices in the elderly, including octogenarians.

In the current study, the researchers found that cardiologists place more emphasis on the procedure of implanting the device, which is a low-risk process by itself, than on the effects of the device on the patient's life after implantation. They propose an initiative that would provide cardiologists with a better way to communicate with their patients.

"Physicians need tools and resources so they can counsel patients about ICDs in a more systematic, judicious and transparent manner," Armbrecht said.

"Cardiologists need to be trained in communication with patients that will promote informed decision making and preempt threats to patient quality of life," Hauptman added.


'/>"/>
Contact: Riya V. Anandwala
ranandwa@slu.edu
314-977-8018
Saint Louis University
Source:Eurekalert

Related medicine news :

1. SEO to Help Doctors and Physicians Put a Lid on Operating Expenses
2. Integrative Health Expert Dr. Tasneem Bhatia Releases What Doctors Eat: Tips, Recipes, and the Ultimate Eating Plan for Lasting Weight Loss and Perfect Health
3. New technology may help doctors monitor concussions, aging, and neurological function
4. Medical School Ethics Policies May Affect How Doctors Prescribe
5. Physicians brain scans indicate doctors can feel their patients pain -- and their relief
6. DoctorSites (Websites for Doctors) Announces Partnership with DPM United to Offer Website Marketing For Doctors
7. Study: Transparent pricing doesnt curb doctors use of high-cost hospital imaging tests
8. Docnosis.com Launches A Smart, New Service That Is Going To Change The Way America Chooses Doctors
9. 1,800 Michigan doctors launch effort to improve health care for Medicare patients
10. Women’s Health and Surgery Center Doctors Named to Top Doctors List
11. Mayo Clinic: Skin problems, joint disorders top list of reasons people visit doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: